Outlook Therapeutics Inc OTLK Valuation Ratios and Share Stats

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Outlook Therapeutics Inc (OTLK)
Outlook Therapeutics Inc (OTLK) Financials

Outlook Therapeutics Inc (OTLK)

1.99

-0.05

(-2.45%)

Closed January 26 3:00PM

Delayed by 15 minutes

1.97

-0.02

(-1.01%)

After Hours: 6:52PM

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End September 29 2024	2017	2018	2019	2020	2021	2022	2023	2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-180.135	-223.256	-182.861	-265.13	-249.92	-257.317	-193.931	-246.604
Return on Equity (%)	206.049	162.237	172.962	734.782	-1430.459	-989.988	2069.216	172.238
Return on Invested Capital (%)	294.989	133.657	167.433	1238.293	-610.626	-566.506	1340.226	159.672
Operating Margin (%)	-858.395	-966.613	-423.128	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	-1050	-1555.019	-442.426	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	-1.35	-0.288	-0.376	0.022	0.026	0.038	-0.055	-2.934
Earnings Per Share	-1.605	-0.665	-1.26	-0.384	-0.301	-0.291	-0.227	-3.026
Cash Per Share	0.128	0.024	0.28	0.099	0.082	0.077	0.09	0.599
Working Capital Per Share	-0.996	-0.398	-0.237	0.016	0.084	0.034	-0.061	-0.608
Operating Profit Per Share	0.153	0.043	0.285	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	-1.538	-0.467	-1.326	-0.303	-0.301	-0.291	-0.227	-3.026
EBITDA Per Share	-1.538	-0.467	-1.326	-0.303	-0.301	-0.291	-0.227	-3.026
Free Cash Flow Per Share	-1.702	-0.669	-1.362	-0.386	-0.302	-0.291	-0.227	-3.026

Liquidity Ratios

Year End September 29 2024	2017	2018	2019	2020	2021	2022	2023	2024
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	24.93M	72.22M	28.61M	127.18M	176.46M	227.31M	N/A	24.91M

Key Stats and Ratios

Year End September 29 2024	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	256.67M	N/A	N/A	N/A	N/A	N/A	N/A	24.91M
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	50.81M
Price to Earnings Ratio	-0.65
Price to Sales Ratio	0
Price to Cash Ratio	3.3
Price to Book Ratio	-0.67
Dividend Yield	-

Share Statistics

Shares Outstanding	24.91M
Average Volume (1 week)	1.13M
Average Volume (1 Month)	1.36M
52 Week Change	-78.25%
52 Week High	12.8499
52 Week Low	0.87

More Ratios Coming Soon!

Outlook Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions